New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are
reported, and epidemiological trends are investigated in a 12-year perspective (2004 to …

As part of a national surveillance programme initiated in 2004, fungal blood isolates from
2016–2018 underwent species identification and EUCAST susceptibility testing. The …

Background The increasing incidence of candidemia and emergence of drug-resistant
Candida species are major concerns worldwide. Long-term surveillance studies are …

The aim of this study was to present the first set of comprehensive data on fungemia in
Denmark including the distribution of species and range of susceptibility to major antifungal …

ABSTRACT A 6-year nationwide study of fungemia in Denmark was performed using data
from an active fungemia surveillance program and from laboratory information systems in …

Significant changes in the management of fungaemia have occurred over the last decade
with increased use of fluconazole prophylaxis, of empirical treatment and of echinocandins …

A semi-national laboratory-based surveillance programme for fungaemia was initiated in
2003 that now covers c. 3.5 million inhabitants (64%) of the Danish population. In total, 1089 …

Candidemia is often a life-threatening infection, with highly variable incidence among
countries. We conducted a nationwide study of candidemia in Iceland from 2000 to 2011, in …

Among 1846 fungal clinical isolates from 31 countries, echinocandin resistance in Candida
spp. ranged from 0.0% to 2.8%(highest for anidulafungin versus Candida glabrata), and …

We analyzed the species distribution of Candida blood isolates (CBIs), prospectively
collected between 2004 and 2009 within FUNGINOS, and compared their antifungal …